Wnt signaling in breast cancer: have we come full circle?
about
Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor proteinWnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-cateninIn vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsA pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genesRapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity.Gene expression profiling of breast cancers with emphasis of beta-catenin regulationIs there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.Isoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-Cadherin and β-catenin complex.LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.Systematical detection of significant genes in microarray data by incorporating gene interaction relationship in biological systems.SFRP1 reduction results in an increased sensitivity to TGF-β signaling.A genome-wide siRNA screen identifies novel phospho-enzymes affecting Wnt/β-catenin signaling in mouse embryonic stem cells.Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progressionChondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells.Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressorPygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion.The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesisLeptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.Inference of tumor phylogenies from genomic assays on heterogeneous samples.Cadherin cell adhesion system in canine mammary cancer: a review.Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosisDiseases of Wnt signaling.Therapeutic targeting of casein kinase 1δ in breast cancerBeta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesisDown-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikisAssociation of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy.Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin.EXPRESSION OF E-CADHERIN AND WNT PATHWAY PROTEINS BETACATENIN, APC, TCF-4 AND SURVIVIN IN GASTRIC ADENOCARCINOMA: CLINICAL AND PATHOLOGICAL IMPLICATIONE3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.Wnt signaling and colon carcinogenesis: beyond APC.
P2860
Q24314166-4761D2E2-57E2-427D-B908-5DDDBE759B3EQ28587260-38E47DED-2F23-462D-BFCD-8D867D7574A1Q29616498-45FC2D53-D5CC-4585-B6E7-4AFFCFB40967Q30566202-F8B9FBDE-E3D0-4D07-B26E-8BEA0C2BF0C4Q33345588-CAAFEE04-7DB0-4BD5-9E76-04AC6EBD2AFCQ33654773-F2F2B139-8B30-4ADB-8711-0DF5EC3AE7E4Q33714951-5A6E2401-B479-41DC-9C6A-B6474306FC85Q33728321-97B05FF6-7A4F-4FE6-AF6E-D452643C528AQ33740256-F8FB63C6-AF79-4E4F-8F87-A6C69BECB530Q33741846-1A8CEB0D-97B1-45BE-927B-64E58A7DC53AQ33814892-FB992C69-1D75-4C2A-BBE0-11EDF35293DCQ33873840-74BD4A26-23BB-4933-B6D4-4BB9732999BCQ33965278-D3305CC6-2B86-4D08-893F-236755417F18Q33999637-3E83A486-CC39-48AF-AC00-C77387525BB7Q34129525-691CE28E-0D5A-4763-952A-A4A9C10BFC63Q34416310-1FC6DA06-25D5-4F7B-BAE8-EBCC2DB3D8C2Q34581026-1A11DD72-445F-42FB-8140-BAE7B411FB99Q34770234-8475ADE4-2E19-4711-8104-7128C1FDAEF8Q34787867-032DDFA5-A156-4779-9102-3FC69E3253EDQ35131418-788A6927-8AEB-4901-851E-802795C8B437Q35399575-725D0738-DD7F-4E58-8A7D-2ADF83AF0527Q35560334-AB800A50-CAD5-43FF-852C-50080EBCA099Q35631729-B1FA91A5-D263-41DB-ABAA-A807380968B7Q35986538-CA34C7D5-3DB2-4F33-B93E-8F94E0A8CD77Q36204016-9BA9169B-75E4-44BF-A08B-DDE49E7AE8CEQ36245519-B129FA8C-D249-4596-9DFB-581CA64090B0Q36324133-A4719412-7725-4673-8799-0DA8C9206D57Q36582366-56E5E70B-C50B-4D8A-99D1-310B9D18C9C6Q36734385-04AF91C4-7A6A-4AFD-98EA-8646F4F2698BQ36857760-984CED4D-6416-4878-A1E8-9E334D91E3E9Q36870645-5F03AE3E-00A3-4F68-AF45-4BC8419F666BQ36936190-3476BE75-9565-4914-B8DD-D627EA196E86Q37158467-A663D5E3-D44C-49D2-92F4-2D3082E6DC11Q37204692-B7165268-9885-477E-8F4E-E23C58A8FE99Q37268494-35299AA3-BE9A-428B-9F3D-4977D5641D7DQ37534512-C67F95E1-4494-4D4D-A89C-9E563FC97425Q37559863-930C7875-5258-4C9B-8BEE-94129E81B652Q37579480-7533C4CD-A3C4-45C2-ABDC-15C8A3962B29Q37658959-D294415A-A69F-4079-84BB-CB8BD83B61F7Q37864083-BD302F29-F8C3-44D1-8ABF-EA62BD29F9A5
P2860
Wnt signaling in breast cancer: have we come full circle?
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Wnt signaling in breast cancer: have we come full circle?
@ast
Wnt signaling in breast cancer: have we come full circle?
@en
Wnt signaling in breast cancer: have we come full circle?
@nl
type
label
Wnt signaling in breast cancer: have we come full circle?
@ast
Wnt signaling in breast cancer: have we come full circle?
@en
Wnt signaling in breast cancer: have we come full circle?
@nl
prefLabel
Wnt signaling in breast cancer: have we come full circle?
@ast
Wnt signaling in breast cancer: have we come full circle?
@en
Wnt signaling in breast cancer: have we come full circle?
@nl
P2860
P921
P356
P1476
Wnt signaling in breast cancer: have we come full circle?
@en
P2093
P2860
P2888
P304
P356
10.1186/BCR321
P407
P577
2001-09-06T00:00:00Z
P5875
P6179
1018011789